Company Quick10K Filing
Fieldpoint Petroleum
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 11 $4
10-Q 2019-05-15 Quarter: 2019-03-31
10-K 2019-04-15 Annual: 2018-12-31
10-Q 2018-11-14 Quarter: 2018-09-30
10-Q 2018-08-14 Quarter: 2018-06-30
10-Q 2018-05-15 Quarter: 2018-03-31
10-K 2018-04-02 Annual: 2017-12-31
10-Q 2017-11-14 Quarter: 2017-09-30
10-Q 2017-08-14 Quarter: 2017-06-30
10-Q 2017-05-15 Quarter: 2017-03-31
10-K 2017-03-31 Annual: 2016-12-31
10-Q 2016-11-14 Quarter: 2016-09-30
10-Q 2016-08-15 Quarter: 2016-06-30
10-Q 2016-05-16 Quarter: 2016-03-31
10-K 2016-03-30 Annual: 2015-12-31
10-Q 2015-11-16 Quarter: 2015-09-30
10-Q 2015-08-14 Quarter: 2015-06-30
10-Q 2015-05-14 Quarter: 2015-03-31
10-K 2015-03-30 Annual: 2014-12-31
10-Q 2014-11-14 Quarter: 2014-09-30
10-Q 2014-08-13 Quarter: 2014-06-30
10-Q 2014-05-14 Quarter: 2014-03-31
10-K 2014-03-27 Annual: 2013-12-31
10-Q 2013-11-14 Quarter: 2013-09-30
10-Q 2013-08-14 Quarter: 2013-06-30
10-Q 2013-05-14 Quarter: 2013-03-31
10-K 2013-03-20 Annual: 2012-12-31
10-Q 2012-11-14 Quarter: 2012-09-30
10-Q 2012-08-14 Quarter: 2012-06-30
10-Q 2012-05-10 Quarter: 2012-03-31
10-K 2012-03-20 Annual: 2011-12-31
10-Q 2011-11-14 Quarter: 2011-09-30
10-Q 2011-08-12 Quarter: 2011-06-30
10-Q 2011-05-13 Quarter: 2011-03-31
10-K 2011-03-30 Annual: 2010-12-31
10-Q 2010-11-15 Quarter: 2010-09-30
10-Q 2010-08-12 Quarter: 2010-06-30
10-Q 2010-05-12 Quarter: 2010-03-31
10-K 2010-03-31 Annual: 2009-12-31
8-K 2019-07-26 Regulation FD, Other Events, Exhibits
8-K 2019-07-19 Accountant, Regulation FD, Exhibits
8-K 2019-07-03 Officers, Regulation FD, Exhibits
8-K 2018-10-26 Shareholder Vote, Officers
8-K 2018-07-25 Enter Agreement, Exhibits
8-K 2018-05-08 Other Events
8-K 2018-04-15 Regulation FD, Exhibits
8-K 2018-01-05 Enter Agreement, Regulation FD, Exhibits

Fieldpoint Petroleum Financials

FPP Metrics, Comps, Filings

Annual | Quarterly

Business

FieldPoint Petroleum Corporation, a Colorado corporation (the “Company”), was formed on March 11, 1980, to acquire and enhance mature oil and natural gas field production in the mid-continent and the Rocky Mountain regions. Since 1980, the Company had engaged in oil and natural gas operations and, in 1986, divested all oil and natural gas assets and operations. From December 1986, until its reverse acquisition on December 31, 1997, the Company did not engage in oil and natural gas operations. Since the reverse acquisition on December 31, 1997 the Company has been in the oil and natural gas exploration and production business.

Our long-term business strategy is to create value by growing reserves and production in a cost efficient manner and at attractive rates of return by pursuing the strategies discussed below. The Company recognizes that the ability to implement its business strategy is largely dependent on the ability to raise additional debt or equity capital to regain compliance with our line of credit agreement (“the Loan Agreement”) before we can fund future acquisition, exploration, drilling and development activities. The Company’s capital resources are discussed more thoroughly in Part II, Item 7, in Management’s Discussion and Analysis.

In response to deteriorating and volatile commodity prices, we halted our drilling activity beginning in 2015, which has led to a natural decline in production. Commodity prices have continued to remain volatile. As of December 31, 2018 and 2017, the Company had a working capital deficit of approximately $3,166,000 and $3,122,000, respectively, primarily due to the classification of our line of credit with Citibank as a current liability. The Loan Agreement provides for certain financial covenants and ratios measured quarterly, which include a current ratio, leverage ratio and interest coverage ratio requirements. The Company was out of compliance with all three ratios as of December 31, 2018 and 2017, and we do not expect to regain compliance in 2019. These factors raise substantial doubt about our ability to continue as a going concern. See Note 2 to our consolidated financial statements in this report for additional information regarding our plans to improve our leverage and our ability to regain compliance with the financial covenants under our revolving credit facility.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Nuo Therapeutics (AURX) 3,796 88% -2.8 -934% 154 1,347 1,156 1,018 -1,442 -1,340 3,787
Patriot Gold (PGOL) 3,714 0% 1,706 233 0 0 0 0 3,601
Encision (ECIA) 3,699 52% -777.5 -4% 4,345 2,168 8,327 4,371 -182 -5 3,563
Innovus Pharmaceuticals (INNV) 3,698 -127% -0.9 -77% 10,837 10,791 2,754 -3,502 -8,358 -6,105 5,258
Blake Insomnia Therapeutics (BKIT) 3,681 -90.8 0 237 0 0 -41 -41 3,681
Geospatial (GSPH) 3,659 71% -5.1 -904% 116 3,479 569 404 -1,052 -713 3,629
Visium Technologies (VISM) 3,647 -2.1 -9,417% 19 3,263 0 0 -1,758 -1,758 3,628
Cartesian (CRTN) 3,632 30% -0.4 -44% 16,522 17,461 47,555 14,053 -7,270 -5,582 2,087
GraniteShares Platinum Trust (PLTM) 3,632 -27.7 -4% 3,656 1 0 0 -131 -131 3,632
Invesco CurrencyShares Singapore Dollar Trust (FXSG) 3,628 0% -60.3 1% 3,637 1 36 0 21 21 -1,288
Fieldpoint Petroleum (FPP) 3,628 0% -1.3 -73% 4,528 6,259 2,144 0 -3,322 -2,684 3,414
American Church Mortgage (ACMC) 3,607 1.9 -0% 39,356 28,807 0 0 -26 1,891 3,607
Immune Pharmaceuticals (IMNP) 3,597 -0.9 -71% 20,716 19,874 0 0 -14,715 -13,953 12,494
American Bio Medica (ABMC) 3,580 30% -8.9 -42% 2,165 2,584 3,643 1,091 -911 -556 4,972
Empire Petroleum (EMPR) 3,576 0% -3.1 -27% 11,766 12,693 2,753 0 -3,134 -3,263 10,156
Genesis Financial (GFNL) 3,571 0% -1.1 -155% 2,427 3,394 10 0 -3,756 -3,242 3,551
Frontier Oilfield Services (FOSI) 3,542 0% 11.0 1% 3,685 11,058 737 0 35 1,043 11,475
Sauer Energy (SENY) 3,496 49% -2.8 -116% 1,092 291 30 15 -1,271 -1,239 3,494
PowerVerde (PWVI) 3,493 0% -8.5 -337% 131 322 31 0 -442 -428 3,655
Puradyn Filter Technologies (PFTI) 3,451 37% -24.8 -33% 2,797 12,529 3,117 1,150 -917 -503 12,470

Balance Sheet ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash2,0381,4082,6489781,467880409285
Accounts Receivable
Inventory
PP&E20,51720,4678,2047,2546,4463,423
Assets21,36323,13524,96322,89810,5208,7707,7134,686
Accounts Payable
Long-Term Debt6,7406,7406,7407,2400
Liabilities12,48711,95412,41311,9309,6439,8215,9116,136
Stockholders' Equity8,87611,18112,55010,968877-1,0511,802-1,450
Income Statement ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Revenue7,23610,40310,5419,2323,9692,8013,0362,170
Cost of Revenue
Gross Profit
R&D
SG&A1,0661,6011,2061,7411,3751,2411,1641,212
Tax3871,174767-1,018-1,9600-151-6
Net Income6032,1121,279-1,948-10,983-2,4732,666-3,252
Cash Flow ($'000)2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-31
Cash Operating3,9813,3344,6833,766700-964-737-160
Cash Investing-2,570-4,157-3,532-6,132-184-1543,795212
Cash Financing-35919490696-27531-3,529-176